Key result
Targeted therapies for early-stage breast cancer carry a risk of adverse cardiovascular effects, necessitating multidisciplinary management and further research on their cardiovascular impact.
Breast cancer survivors face a significant risk of cardiovascular disease due to antineoplastic treatments, necessitating a multidisciplinary approach to manage and prevent these complications.
No takes yet. Share an insight, caveat, or question.
Integrates cardio-oncology into early breast cancer care; leaves open precise risk mitigation pending prospective trials.
Maurea et al. (2010) conducted a review in Breast cancer. Targeted therapy was evaluated. Targeted therapies for early-stage breast cancer carry a risk of adverse cardiovascular effects, necessitating multidisciplinary management and further research on their cardiovascular impact.